Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR (Q84610115)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667790%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667790%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667790%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Peter A Ringleb

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667790%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

4

Michael Hennerici

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667790%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Nils Wahlgren

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667790%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Martin Grond

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667790%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Kennedy R Lees

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667790%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Robert Mikulik

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667790%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Mark Parsons

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667790%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Risto O Roine

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667790%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Danilo Toni

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667790%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

SITS investigators

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667790%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

26 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667790%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667790%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667790%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667790%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

866-874

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667790%20AND%20SRC:MED&resulttype=core&format=json

Tissue plasminogen activator for acute ischemic stroke

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970165-4

7 January 2021

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970165-4

7 January 2021

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970165-4

7 January 2021

Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970165-4

7 January 2021

The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970165-4

7 January 2021

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970165-4

7 January 2021

Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970165-4

7 January 2021

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970165-4

7 January 2021

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970165-4

7 January 2021

Thrombolysis for acute ischaemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970165-4

7 January 2021

Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970165-4

7 January 2021

Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970165-4

7 January 2021

Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970165-4

7 January 2021

Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970165-4

7 January 2021

Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970165-4

7 January 2021

National Institutes of Health Stroke Scale certification is reliable across multiple venues

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970165-4

7 January 2021

10.1016/S1474-4422(10)70165-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667790%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference